Clinical trials in allergic conjunctivits: a systematic review
F Mantelli1, A Lambiase, S Bonini
1Department of Ophthalmology, Campus Bio-Medico University of Rome, Rome.
Allergy
|January 26, 2011
Summary
Clinical trials for ocular allergy often lack standardized designs and objective measures, leading to limited evidence for effective management. Future research needs consistent criteria for patient selection and outcome evaluation to improve treatment recommendations.
Area of Science:
- Ophthalmology
- Allergy Research
- Clinical Trial Design
Background:
- Ocular allergy is a prevalent condition managed by allergists and ophthalmologists.
- Existing clinical trial designs for allergic conjunctivitis vary significantly, yielding conflicting evidence.
- A systematic review was conducted to assess the quality of these trials and identify design biases.
Purpose of the Study:
- To critically evaluate the quality of clinical trials in allergic conjunctivitis.
- To identify biases in existing research that should be avoided in future studies.
- To provide recommendations for improving the design of ocular allergy clinical trials.
Main Methods:
- A systematic review of clinical trials in allergic conjunctivitis published since 1965 was performed.
- Data extraction included patient characteristics, interventions, comparisons, and outcomes.
- Trial quality was independently assessed by four authors using the Jadad scale.
Main Results:
- 362 trials were included in the review.
- Few trials met all criteria for robust clinical trial design.
- Limited use of objective parameters for patient selection and efficacy/safety evaluation was noted.
- Crucial outcomes like disease relapse and recurrence were frequently omitted.
Conclusions:
- The evidence base from current ocular allergy trials is insufficient to strongly guide healthcare providers and policymakers.
- Standardized diagnostic criteria for patient selection are recommended.
- Quantifiable primary outcomes are essential for enhancing future clinical trial design in allergic conjunctivitis.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:06Allergic Reactions
Overview
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...